Patents by Inventor Daniel Shin-Yu Chen

Daniel Shin-Yu Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20220363764
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: March 4, 2022
    Publication date: November 17, 2022
    Inventors: Daniel Shin-Yu CHEN, Priti HEGDE, Hartmut KOEPPEN, Marcin KOWANETZ
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20220146517
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: August 16, 2021
    Publication date: May 12, 2022
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • Biomarkers and methods of treating PD-1 and PD-L1 related conditions
    Patent number: 11299544
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: April 12, 2022
    Assignee: Genentech, Inc.
    Inventors: Daniel Shin-Yu Chen, Priti Hegde, Hartmut Koeppen, Marcin Kowanetz
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20210140967
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: January 14, 2021
    Publication date: May 13, 2021
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20200333348
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: May 20, 2020
    Publication date: October 22, 2020
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20200041520
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: October 18, 2019
    Publication date: February 6, 2020
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20190195882
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: February 22, 2019
    Publication date: June 27, 2019
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20180313845
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 1, 2018
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20170052188
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: June 29, 2016
    Publication date: February 23, 2017
    Applicant: Genentech, Inc.
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20160222118
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: September 10, 2015
    Publication date: August 4, 2016
    Applicant: GENENTECH, INC.
    Inventors: Daniel Shin-Yu CHEN, Priti HEGDE, Hartmut KOEPPEN, Marcin KOWANETZ
  • BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
    Publication number: 20150071910
    Abstract: Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: March 12, 2014
    Publication date: March 12, 2015
    Applicant: Genentech, Inc.
    Inventors: Marcin KOWANETZ, Daniel Shin-Yu CHEN, Hartmut KOEPPEN
  • METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
    Publication number: 20110151468
    Abstract: Disclosed herein are methods and compositions useful for identifying therapies likely to confer optimal clinical benefit for patients with cancer.
    Type: Application
    Filed: November 19, 2010
    Publication date: June 23, 2011
    Applicant: Genetech, Inc.
    Inventors: Thomas D. Wu, Daniel Shin-Yu Chen, Jennifer Le Couter
  • MHC-antigen arrays for detection and characterization of immune responses
    Patent number: 7902121
    Abstract: T cells are profiled with respect to their expression of antigen receptor. The cells are arrayed on a planar or three-dimensional substrate through binding to immobilized or partially diffused MHC-antigen complexes. The cells may further be characterized with respect to their ability to respond to external stimulus in the microenvironment. External stimuli include cell-cell interactions, response to factors, and the like.
    Type: Grant
    Filed: May 27, 2004
    Date of Patent: March 8, 2011
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Daniel Shin-Yu Chen, Yoav Soen, Daniel Lewis Kraft, Patrick O. Brown, Mark Davis
  • METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
    Publication number: 20090123930
    Abstract: Disclosed herein are methods and compositions useful for identifying therapies likely to confer optimal clinical benefit for patients with cancer.
    Type: Application
    Filed: November 5, 2008
    Publication date: May 14, 2009
    Inventors: Thomas D. Wu, Daniel Shin-Yu Chen, Jennifer Le Couter